Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Schizophrenia

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Schizophrenia in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Villar-Menéndez, I1
Díaz-Sánchez, S1
Blanch, M1
Albasanz, JL1
Pereira-Veiga, T1
Monje, A1
Planchat, LM1
Ferrer, I1
Martín, M1
Barrachina, M1
Lillrank, SM1
Lipska, BK1
Weinberger, DR1
Fredholm, BB1
Fuxe, K1
Ferré, S1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Schizophrenia

ArticleYear
Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.
    Journal of psychiatric research, 2014, Volume: 51

    Topics: Actins; Adenosine A1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Cell M

2014
Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
    Neurochemistry international, 1999, Volume: 34, Issue:3

    Topics: Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Corpus Striatum; Disease Models, Anim

1999